| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 682756 | Spiro[4H-1-benzazepine-4,1'-cyclohexane]-2,5(1H,3H)-dione, 4'-(4-chlorophenyl)-3'-[(4-chlorophenyl)carbonyl]- 4'-hydroxy- | 0.0222343516878698 | -0.068927436 |
| NSC 692577 | Null | 0.0222343516878698 | 0.5210229 |
| NSC 109451 | Null | 0.0244632509325736 | -0.24363342 |
| NSC 123461 | Ethanesulfonic acid, compd. with 4-[[3-[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenyl]-1-oxopropyl]amino]benzenesulfonyl fluoride (1:1) (9CI) | 0.0244632509325736 | 0.23009047 |
| NSC 150862 | BLEOMYCIN FRACTION BLM-HPE | 0.0244632509325736 | 0.011425497 |
| NSC 175633 | 4(1H)-Quinazolinone, 2-(2-chlorophenyl)-2,3-dihydro- | 0.0244632509325736 | 0.32553982 |
| NSC 278631 | 2-Butenoic acid, 3-[(1,3-dihydroxy-2-naphthalenyl)thio]-, ethyl ester, (Z)- | 0.0244632509325736 | 0.35289888 |
| NSC 309401 | 2H-Pyrrolo[3,2-f]quinazoline-2,4(3H)-diamine, 3-[(3-aminophenyl)methyl]-, dihydrochloride | 0.0244632509325736 | 0.23926774 |
| NSC 312887 | Fludarabine phosphate | 0.0244632509325736 | 0.23796508 |
| NSC 32937 | Benzenamine, 4-(9-chloro-10-ethyl-9,10-dihydro-9-acridinyl)-N,N-dimethyl-, dihydrochloride | 0.0244632509325736 | 0.37603068 |